The Physical Relationship between Infectivity and Prion Protein Aggregates Is Strain-Dependent by Tixador, Philippe et al.
The Physical Relationship between Infectivity and Prion
Protein Aggregates Is Strain-Dependent
Philippe Tixador, Lae ¨titia Herzog, Fabienne Reine, Emilie Jaumain, Je ´ro ˆme Chapuis, Annick Le Dur,
Hubert Laude*, Vincent Be ´ringue*
INRA (Institut National de la Recherche Agronomique), UR892, Virologie Immunologie Mole ´culaires, Jouy-en-Josas, France
Abstract
Prions are unconventional infectious agents thought to be primarily composed of PrP
Sc, a multimeric misfolded conformer
of the ubiquitously expressed host-encoded prion protein (PrP
C). They cause fatal neurodegenerative diseases in both
animals and humans. The disease phenotype is not uniform within species, and stable, self-propagating variations in PrP
Sc
conformation could encode this ‘strain’ diversity. However, much remains to be learned about the physical relationship
between the infectious agent and PrP
Sc aggregation state, and how this varies according to the strain. We applied a
sedimentation velocity technique to a panel of natural, biologically cloned strains obtained by propagation of classical and
atypical sheep scrapie and BSE infectious sources in transgenic mice expressing ovine PrP. Detergent-solubilized, infected
brain homogenates were used as starting material. Solubilization conditions were optimized to separate PrP
Sc aggregates
from PrP
C. The distribution of PrP
Sc and infectivity in the gradient was determined by immunoblotting and mouse bioassay,
respectively. As a general feature, a major proteinase K-resistant PrP
Sc peak was observed in the middle part of the gradient.
This population approximately corresponds to multimers of 12–30 PrP molecules, if constituted of PrP only. For two strains,
infectivity peaked in a markedly different region of the gradient. This most infectious component sedimented very slowly,
suggesting small size oligomers and/or low density PrP
Sc aggregates. Extending this study to hamster prions passaged in
hamster PrP transgenic mice revealed that the highly infectious, slowly sedimenting particles could be a feature of strains
able to induce a rapidly lethal disease. Our findings suggest that prion infectious particles are subjected to marked strain-
dependent variations, which in turn could influence the strain biological phenotype, in particular the replication dynamics.
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Introduction
Transmissible spongiform encephalopathies (TSE), such as
human Creutzfeldt-Jakob disease, sheep scrapie, bovine spongi-
form encephalopathy (BSE) and chronic wasting disease of
cervidae, are infectious, fatal, neurodegenerative disorders caused
by prions [1]. Prions are unconventional pathogens primarily
composed of PrP
Sc, a rearranged conformer of the ubiquitously
expressed prion protein (PrP
C), whose precise physiological
function is largely unknown. Upon infection, PrP
Sc dictates the
self-perpetuating conformational conversion of PrP
C into nascent
PrP
Sc. This conversion involves – without any apparent post-
translational modification – the refolding of soluble, alpha-helix-
rich PrP
C molecules into beta-sheet enriched PrP
Sc polymers that
form deposits in TSE-infected brains [2,3] and are assumed to be
responsible for the observed neurodegenerative disorders [4]. The
conversion reaction may proceed through a nucleated polymer-
ization mechanism in which PrP
Sc multimers recruit PrP
C
molecules and trigger their conformational conversion into PrP
Sc
(for review [5]). The refolding/multimerisation process confers
distinct physico-chemical properties to PrP
Sc, such as insolubility
in non-denaturing detergents and partial resistance to proteolysis
[6].
Distinct prion entities, referred to as strains, are known to self-
propagate in the same host and exhibit distinguishable phenotypic
traits that are heritable, such as incubation time, neuropatholog-
ical and biochemical properties (for reviews: [7,8,9]). Accumulat-
ing experimental evidence indicates that strain-specified properties
are encoded within structural differences in the conformation of
the PrP
Sc molecules, which are faithfully imparted to host PrP
C
during the conversion process [10,11,12,13,14,15,16,17]. Howev-
er, the extent to which the aggregation state varies between
different stains, and participates to strain-specific prion biology is
unknown. The various fractionation methods and preparative
procedures previously employed to estimate the size of the
infectious particles [18,19,20,21,22,23,24,25] have led to a vast
range of measured sizes, making it difficult to relate any variation
to potential strain differences. Of note, almost all of these studies
used substantially purified PrP
Sc as a starting material.
In this study, we developed a specific protocol to fractionate PrP
particles according to their sedimentation velocity properties in a
viscous medium, characterized their relative levels of infectivity
and looked for strain-specific variations. In contrast to previous
reports, experiments were performed on crude brain homoge-
nates, which a priori contain all TSE infectivity. We worked with a
panel of strains that were biologically cloned on homogeneous
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and atypical (Nor98) sheep scrapie and BSE, or hamster scrapie
infectious sources in transgenic mice expressing ovine PrP (VRQ
allele; tg338 mice) and hamster PrP (tg7 line), respectively. We
demonstrate that the sedimentation profile of the infectious
component dramatically varies with the strain. We further show
that the predominance of slowly sedimenting infectious particles
that segregate from the bulk of proteinase K-resistant PrP
Sc
particles may be a distinctive feature of strains able to induce a
rapidly lethal disease.
Results
Optimizing the conditions to analyze non-denatured
PrP
Sc polymers by sedimentation velocity
PrP
Sc aggregates present in detergent-solubilised brain tissue
homogenates were fractionated by sedimentation velocity centri-
fugation in an iodixanol gradient (Optiprep). The experimental
conditions were established with brain material from tg338 mice
that were infected or not with LA21K fast strain (referred to as
LA21K), a prototypal, rapid strain that kills the mice within ,2
months (see Table 1 for information on the strains used in this
study). As a first step, we tested a variety of detergents for
solubilization, which showed variable efficacy in terms of partition
of PrP
C and PrP
Sc species. For example, the use of standard
solubilization buffers containing Triton X-100 and sodium
deoxycholate or sarkosyl led to sedimentation of both isoforms
throughout the gradient (Figure S1), indicating an incomplete
release of total PrP from cellular constituents. In contrast, the
sequential use of dodecyl maltoside and sarkosyl resulted in more
efficient separation of the two PrP isoforms. Thus, in the
conditions eventually employed (see Figure 1 for a summarizing
flow diagram), the bulk of PrP
C molecules remained in the upper
fractions 1–4 (Figure 2A and D, green line), while both PrP
Sc
(Figure 2B) and proteinase K (PK) resistant PrP
Sc species
(Figure 2C–D, black line) were mainly detected in fractions 6–
20 of the gradient. Importantly, no pelleted PrP material was
Author Summary
Prions are unconventional transmissible agents causing
fatal neurodegenerative diseases in human and animals.
They are thought to be formed from polymers of abnormal
conformations of the host-encoded prion protein (PrP),
but little is known about the physical organization of the
infectious particles and any relationship between packing
order and infectivity. As an additional layer of complexity,
different PrP conformational variants associated with
distinct biological phenotypes, or ‘strains’, can propagate
in the same host. We subjected PrP polymers from eight
different ovine and hamster prion strains to sedimentation
velocity centrifugation, which allows separation of macro-
molecular complexes according to their size, density or
shape. We showed that, whereas the PrP sedimentation
profiles share common features, the infectivity profiles
exhibit striking differences amongst the strains. For four of
them, the infectious component was predominantly
associated with slowly sedimenting particles, suggestive
of small size oligomers and/or low density PrP aggregates.
Such particles appeared to be a feature of strains able to
induce a rapidly lethal disease in the recipient host. Our
findings suggest that prion infectious particles are
subjected to marked strain-dependent variations, which
in turn could influence the strain biological phenotype, in
particular the replication dynamics.
Table 1. Phenotypic traits of the ovine and hamster prion
strains used in the study.
Strains
1 Survival time
2 PrP
res pattern
3 References
Ovine
LA21K (fast)5 5 61 21 kDa Unpublished
127S 5661 21 kDa [61]
LA19K 13363 19 kDa Unpublished
BSE 13563 20 kDa [60]
Nor98 186641 9 k D a +10 kDa [41]
Hamster
139 H 3661 21 kDa [67] and unpublished
Sc237 4561 21 kDa [67] and unpublished
ME7H 14163 21 kDa Unpublished
1All but ME7H have been cloned by transmission at limiting dilution.
2Measured in recipient transgenic mice expressing ovine PrP (tg338 line) or
hamster PrP (tg7 line). Expressed as mean (in days) 6 SEM.
3As referred to the size of unglycosylated PK-resistant PrP
Sc in immunoblots.
doi:10.1371/journal.ppat.1000859.t001
Figure 1. Flow diagram describing the sedimentation velocity
protocol and the analysis of prion particles infectivity with
regard to PrP
Sc content.
doi:10.1371/journal.ppat.1000859.g001
Strain Variation in Prion Infectious Particles
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gation time caused the majority of PrP
Sc to sediment toward the
heaviest fractions of the gradient, indicating that this material had
not reached its density equilibrium (data not shown). Both dodecyl
maltoside and sarkosyl are known to efficiently solubilize
membrane structures, including rafts [26,27,28], yet PrP
Sc could
be attached to abnormal, prion-induced structures. To address this
point, brain homogenates were solubilized using these detergents
in more stringent conditions, i.e. at 37uC instead of 4uC [29],
however the sedimentation profile of PrP
Sc was affected only
marginally (Figure S2A).
In order to assess the reproducibility of the partition and to
enable quantitative analysis of the data, 7 independent fraction-
ations were performed using different pooled or individual brains
and the resulting data fitted (Figure 3A, black line). This revealed
that ,80% of the PK-resistant PrP
Sc material sedimented as one
major peak (maximum in fractions 10–12) with a Gaussian-like
distribution. Standard globular macromolecules and ovine recom-
binant PrP oligomers [30] loaded on gradients run in parallel
enabled estimation of the approximate molecular mass of the PK-
resistant PrP
Sc aggregates forming the peak in fraction 10–12:
between 200 and 500 kDa (by reference to the marker proteins,
the sedimentation profile of which was affected only marginally in
the presence of detergents), and ,850 kDa based on the position
of the 36-mer PrP oligomer (Figure 3A).
When solubilized brain material was PK-treated prior to
ultracentrifugation, the PrP
res sedimentation profile resembled
that observed with intact brain material (Figure S2B). However,
when semi-purified PrP
Sc in the form of scrapie-associated fibrils
[31,32] was resolubilized and centrifuged, a markedly different
profile was obtained, with peaks in fractions 22 and 30 (bottom
fraction) (Figure S2C). Interestingly, fast sedimenting PrP
Sc
material was also observed with Italian scrapie agent (referred to
as SSit), which in tg338 mice produces very long incubation times
and abundant plaque-like PrP
Sc deposits in the brain [33], in
contrast to the LA21K agent. These plaques can be stained by
thioflavin S (Figure S3A–B), indicating the presence of amyloid
fibrils. When SSit-infected brain material was fractionated, the
majority of PrP
Sc multimers peaked in fractions 24 to 30 of the
gradient (Figure S3C).
These results suggest that the experimental conditions employed
preserve potential differences in the aggregation state of PrP
Sc
thereby enabling the comparative analysis of sedimentation
properties of ‘‘close to natural’’ PrP
Sc aggregates and of associated
infectivity.
Fast ovine prion strains have distinct infectivity and PK-
resistant PrP
Sc sedimentation profiles
The distribution of prion infectivity throughout the gradients
was determined by an incubation time bioassay [34]. tg338 mice
were inoculated intracerebrally with diluted aliquots from the
different fractions. In terminally diseased mice, the PrP
Sc
electrophoretic profile and regional distribution in the brain
observed for representative fractions were both consistent and
similar to that with the original brain material, indicating a
conservation of the strain biological phenotype (Figure S4A and
data not shown). The mean survival time values resulting from the
analysis of 2 independent gradients are shown in Figure 3A (red
line). Typically, the mice inoculated with the PK-resistant PrP
Sc-
richest fractions (6–20) succumbed to disease in more than 80
days, whereas those inoculated with fractions 1–3 died in a
markedly shorter time, ,60–70 days. The correlation between the
mean survival time values and infectivity was established by using
a standard infectious dose/survival time curve previously estab-
lished for this strain (Figure S5). This analysis indicated that
fractions 1–2 were between 100- and 1000-fold more infectious
than fractions 6–20 (Figure 3A, blue scale). These upper fractions
- within the sedimentation peak of aldolase (158 kDa) and
upstream of 12-mer PrP oligomer – totaled ,10% of PK-resistant
PrP
Sc molecules (Figure 3A).
There is substantial evidence to indicate that a fraction of PrP
Sc
can exhibit low sedimenting properties and be PK-sensitive
[28,35,36]. Recently, thermolysin has been used as a means to
isolate PK-sensitive forms of PrP
Sc, while degrading PrP
C [37].
When the upper fractions from LA21K gradients were thermol-
ysin-digested, no enrichment in thermolysin-resistant species was
observed by immunoblot as compared to unfractionated brain
material (Figure S6A–C). To further analyze the forms of PrP
Sc
present in the upper fractions, aliquots were centrifuged at
100 000 g for 1 h to produce soluble (supernatant) and insoluble
(pellet) fractions, before immunoblot analysis. The ratio of soluble
and insoluble PrP species in LA21K versus uninfected fractions
was determined based on signal intensities. As a result, the top two
LA21K fractions were reproducibly shown to contain equivalent
amounts of soluble material and about 2-fold more sedimentable
material as compared to the corresponding uninfected fractions
(Figure S6D).
Detergents and lipids have been proposed to increase the
apparent infectious titer of PrP
Sc preparations non-specifically
[38,39] and such compounds are relatively abundant in the upper
fractions of the gradient. To test whether such an effect was
responsible for the comparatively high infectivity levels of the top
fractions, the PK-resistant PrP
Sc-enriched fractions 10 to 12 were
mixed, incubated with either the top fractions 1 to 3 of a gradient
made with uninfected tg338 brain or with dodecyl maltoside alone,
and inoculated to mice. As a result, in either condition, the relative
titer of these fractions was not significantly modified (Figure 4).
To confirm that the differences in survival times observed
between mice inoculated with the various fractions were correlated
with differences in infectivity content, a mouse-free, cell bioassay
was used. The distribution and level of LA21K infectivity in the
gradient was measured using Rov cells [40] that were exposed in
parallel to fraction aliquots and to serial tenfold dilutions of a
LA21K brain homogenate prepared in the same conditions.
Consistent with the bioassay data, the most infectious fractions
were found at the top of the gradient and were $100-fold more
infectious than the middle fractions (Figure S7).
Overall these data indicate that the upper fractions were
intrinsically highly infectious. The fact that the cumulated
infectivity in the gradient fractions did not differ significantly
from that present in the loaded material prior solubilization also
supports the conclusion that the detergents used did not alter
infectivity estimates.
Brains of tg338 mice infected by another fast ovine strain named
127S (Table 1) were also fractionated and analyzed for PrP and
infectivity content. 127S PK-resistant PrP
Sc peaked in fractions
Figure 2. Immunoblot analysis of velocity sedimented PrP material from tg338 mouse brain. Brain homogenates from uninfected (A)o r
scrapie-infected (B–C; LA21K strain) tg338 mice were solubilized and fractionated by sedimentation velocity. The collected fractions (numbered from
top to bottom of the gradient) were analyzed for PrP content by immunoblot without (A, B) or after PK digestion (C). (D) Graph showing the relative
amount of PrP
C (green line) and PK-resistant PrP
Sc (black line) per fraction. MM: molecular markers.
doi:10.1371/journal.ppat.1000859.g002
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variation of the sedimentation profile in the bottom part of the
gradient. Strikingly, the sedimentation profile of infectivity again
largely segregated from that of PK-resistant PrP
Sc as assessed by
mouse bioassay. The top two fractions were at least 50–100-fold
more infectious than all the other fractions, including the major
PK-resistant PrP
Sc peak (Figure 3B).
Infectivity and PK-resistant PrP
Sc sedimentation profiles
of ‘‘slow’’ ovine strains
We next examined whether the decoupling of PK-resistant
PrP
Sc and infectivity sedimentation profiles was a general feature
of ovine strains. Three more strains were studied of which the
incubation time in tg338 mice is at least twice that of LA21K and
127S: LA19K, Nor98 and sheep BSE (see Table 1). Four to five
independent fractionations with different pooled or individual
brains were performed for each strain. The combined curves
resulting from the replicate analysis of PrP content indicated that
a majority of PK-resistant PrP
Sc peaked in fractions 10–12,
similar to that seen with the two fast strains. However, faster
sedimenting species were also observed, notably in fractions 16,
20 for LA19K and fractions 22–24 for Nor98 (Figure 3C–D).
Remarkably, the infectivity sedimentation profile of these 3
strains, as established from bioassay of two independent
gradients, tended to overlap PK-resistant PrP
Sc distribution, with
a very small proportion of the total infectivity in the top fractions.
LA19K most infectious fractions ranged from fractions 8 to 24
with a peak in fraction 20 (range of mean survival time: 152 to
163 days), while the top and bottom fractions were ,100-fold less
infectious (mean survival time ,185 to 210 days; Figure 3C).
Nor98 infectivity peaked in fraction 11 and to a lesser degree in
fraction 17 and 22 (mean survival time 222, 240 and 245 days,
respectively; Figure 3D). Fractions in the immediate vicinity of
these peaks were among the most infectious, (except fraction 13).
In contrast, the upper fractions were ,100-fold less infectious
(survival time prolonged by .40 days). The most infectious sheep
BSE fractions were found in fractions 6–12, 16 and 20 (mean
survival times of 155–160, 164 and 163 days) while the top and
bottom fractions were about 50-fold and 100-fold less infectious,
respectively (survival time of ,175 days and .180 days;
Figure 3E).
Sedimentation properties of hamster prions
To further explore the possibility that slow sedimenting
infectivity could be a specific feature of fast prion strains, we
applied the same sedimentation velocity protocol to three hamster
strains passaged on tg7 transgenic mice expressing hamster PrP
(Table 1). For fast strains 139H and Sc237, the infectivity peaked
in the top two fractions, which contained ,10% of the total PK-
resistant PrP
Sc material present in the gradient. The two 139H
PK-resistant PrP
Sc peaks in fractions 11–12 and 16–18 and the
Sc237 PK-resistant PrP
Sc peak in fraction 11–12 were ,50-fold
and ,10-fold less infectious, respectively (n=2 independent
experiments made with different individual brains; Figure 5A–
B). ME7H strain, characterized by a longer incubation time,
produced a different picture since the mice inoculated with the
PK-resistant PrP
Sc peak in fraction 11 were the fastest to succumb
to disease, i.e. ,180 days, whereas those inoculated with the top 3
fractions had mean survival times significantly prolonged by 20 to
40 days (Figure 5C). Therefore, much less infectivity was present
in the upper region of the gradient than in the PK-resistant PrP
Sc
containing fractions (about 50–100-fold, based on the available
results of the endpoint titration of ME7H, still ongoing).
Collectively, the contrasted sedimentation properties of fast and
Figure 3. Distinct PK-resistant PrP
Sc and infectivity sedimentation profiles of ovine prion strains. Brain homogenates from tg338 mice
infected with LA21K (A), 127S (B), LA19K (C), Nor98 (D) and sheep BSE (E) were solubilized and fractionated by sedimentation velocity. Fractions
collected from the gradient were analyzed for PK-resistant PrP
Sc content (black line) and for infectivity (red line). The mean levels of PK-resistant PrP
Sc
per fraction have been obtained from the immunoblot or ELISA analysis of n=4 to 7 (as indicated on each graph) independent fractionations. Since
the replicates gave consistent results, these data were combined and fit. For each fraction, the percentage of total PK-resistant PrP
Sc detected on the
immunoblot is presented (left axis). For each fraction of each strain, infectivity was determined by measuring mean survival times in reporter tg338
mice (mean 6 SEM; right, red axis) and by applying these values to standard dose response curves [34], established by inoculation of serial tenfold
dilutions of mouse brain homogenates infected with the same strain (see Figure S5 and material and methods). In these titration experiments,
animals inoculated with 2 mg of infectious brain tissue were assigned a relative infectious dose of 0. The right, blue logarithmic scale provides the
strain-specific reciprocal relation between survival time and relative infectious dose. For all but 127S strain, the data presented are the mean of n=2
independent titrations. The sedimentation peaks of standard molecular mass markers (MM markers) aldolase (158 kDa), catalase (232 kDa), ferritin
(440 kDa), thyroglobulin (669 kDa) and of 12-, 24-, and 36-mers of ovine recombinant PrP (recPrP) oligomers are indicated on the top of the graph.
doi:10.1371/journal.ppat.1000859.g003
Figure 4. Effect of cellular components or detergent present in
the gradient top fractions on infectivity of the LA21K PK-
resistant PrP
Sc–richest fractions. LA21K PK-resistant PrP
Sc-richest
fractions 11 to 13 (fr11–13) were mixed together and incubated (vol:vol)
with either the upper fractions 1 to 3 (fr1–3) of a gradient made with
uninfected tg338 mouse brain (NI) or with dodecyl maltoside (DDM) at
2% (wt/vol.) final concentration. The specific influence of sarkosyl was
not tested since the gradients were prepared in a solution containing
this detergent (see methods). The resulting mixture was inoculated to
recipient mice. Their relative infectious titer was estimated by an
incubation time bioassay, and compared to that of the fractions 1 to 3
of the same gradient pooled and diluted in 5% glucose (vol:vol). The
infectious titers are expressed as relative infectious doses as in Figure 3.
doi:10.1371/journal.ppat.1000859.g004
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Sc and infectivity sedimentation profiles of hamster prion strains. Brain homogenates from tg7 mice
infected with 139H (A), Sc237 (B) and ME7H (C) strains were solubilized and fractionated by sedimentation velocity. Fractions collected from the
gradients were analyzed for PK-resistant PrP
Sc content by immunoblot (black line) and for infectivity by an incubation time bioassay (A–B; red line). The
mean levels of PK-resistant PrP
Sc per fraction have been obtained from the immunoblot or ELISA analysis of n=2 to 3 (as indicated on each graph)
independent fractionations. Since the replicates gave consistent results, these data were combined andfit. For each fraction, the percentage of total PK-
resistant PrP
Sc detected on the immunoblot is presented (left axis). For all but ME7H strain, infectivity per fraction was determined by measuring mean
survival times in reporter tg7 mice (mean 6 SEM; right, red axis) and by applying these values to standard dose response curves, established by
inoculation of serial tenfold dilutions of mouse brain homogenates infected with the same strain (see Figure S5 and material and methods). In these
titration experiments, animals inoculated with 2 mg of infectious brain tissue were assigned a relative infectious dose of 0. The right, blue logarithmic
scale provides the strain-specific reciprocal relation between survival time and relative infectious dose. For all but ME7H strain, the data presented are
the mean of n=2 independent titrations. For ME7H, the mean survival time (C) is shown (no titration curve available yet). *The mean survival times of
miceinoculatedwithME7Hfraction1,2 and4 weresignificantly prolongedcomparedtothatofmiceinoculatedwithfraction11(p,0.05, Kruskall-Wallis
test). The sedimentation peaks of standard molecular mass markers (MM markers) aldolase (158 kDa), catalase (232 kDa), ferritin (440 kDa),
thyroglobulin (669 kDa) and of 12-, 24-, and 36-mers of ovine recombinant PrP (recPrP) oligomers are indicated on the top of the graph.
doi:10.1371/journal.ppat.1000859.g005
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the ovine strains.
Discussion
Here we compared the sedimentation velocity properties of the
infectivity and of abnormal PrP amongst several prion strains,
using experimental conditions aimed at preserving as much as
possible the ‘‘natural’’ multimerization state of the prion particles
while minimizing artifacts due to improper membrane solubiliza-
tion. To our knowledge this is the first study that allows a rigorous
comparison of phenotypically distinct strains, cloned and propa-
gated on the same genetic background. We found striking, strain-
specific differences in the sedimentation profile of the infectious
prion particles, which are not reflected in the sedimentation
properties of the bulk of PrP
Sc.
Fractionation of five tg338 mouse-passaged ovine prions
revealed a major PK-resistant PrP
Sc population, which peaked
at the same position of the gradient regardless of the strain. By
comparison with standard molecular mass markers and recombi-
nant ovine PrP oligomers [30], we estimated that this population
might correspond to approximately 12–30 PrP monomers
averaging ,30 kDa each, if constituted of PrP only, with the
caveat that great caution must be exercised when attributing a size
to a polymer by comparing its velocity to that of molecular mass
markers. This result suggests that PrP
Sc is not a collection of
multimers with a regular continuum of size. However, the overall
sedimentation profiles were not uniform among the strains,
indicating that the size distribution of PrP
Sc aggregates is strain-
dependent. tg7 mouse-passaged hamster prions showed PrP
Sc
sedimentation characteristics resembling that of ovine strains, with
the same position of the major peak and limited variation. Greater
differences in the size distribution of PrP
Sc aggregates may
however exist depending on strain and/or PrP sequence, since
one amyloid-forming ovine prion (Italian scrapie; Figure S3)
showed a clear shift of PrP
Sc toward heavier fractions of the
gradient.
In two studies, larger polymers were shown to be more PK-
resistant than smaller ones [28,35], indicating that the resistance to
proteolysis of PrP
Sc largely depends on its quaternary structure.
The PrP
Sc associated with Nor98 agent, a newly discovered strain
responsible for an atypical form of field scrapie, is highly sensitive
to PK digestion, when compared to the other ovine strains studied
here [41,42]. Notwithstanding, Nor98 PrP
Sc exhibited not only the
same predominant peak as the other strains, but also the highest
proportion of faster sedimenting PrP
Sc species. This argues that
the pronounced PK sensitivity of Nor98 PrP
Sc is not due to low
size aggregates, but rather to its tertiary structure. Supporting this
view, its C-terminal region is accessible to PK, in contrast to
classical scrapie agents [43,44].
The infectivity sedimentation profiles unexpectedly contrast
with that of the PrP
Sc aggregates. While infectivity and PK-
resistant PrP
Sc roughly co-fractionated for LA19K, Nor98 and
sheep BSE, their respective distribution was mostly decoupled for
LA21K and 127S: with these two fast strains, infectivity essentially
partitioned in the upper fractions, which were 2–3 logs more
infectious than the PK-resistant PrP
Sc–richest fractions. LA21K,
127S and Nor98 are three strains exhibiting similarly high
infectious titers in tg338 mice, making the observed differences
particularly striking. Remarkably, a comparable situation was
observed for hamster strains. Thus, ME7H infectivity and PK-
resistant PrP
Sc sedimentation velocity profiles were broadly
congruent, whereas for the fast strains 139H and Sc237 the
infectivity peaked in the upper region of the gradient. Altogether,
these findings lend support to the view that the predominance of
slow sedimenting particles may be a common feature of prion
strains with short incubation time.
Such a decoupling between infectivity and PK-resistant PrP
Sc
with respect to the size of the particles is to our knowledge
unprecedented in the literature. Two earlier studies performed
with fast hamster prions [18,23] also reported a relatively low
PrP
res content of the most infectious fractions. However, the level
of infectivity in these fractions did not exceed that of the PrP
res-
richest fractions. The preparations used were fibrillar PrP
res
material under the form of SAF or Rods, disaggregated by
sonication in the presence of anionic detergents [18,23]. Such a
procedure is likely to destroy discrete subpopulations of infectious
particles, which may explain the observed discrepancy.
Which form(s) of PrP
Sc could support the high infectivity of the
fast strains’ slow sedimenting component? One possibility is that it
consists essentially of PK-resistant aggregates, with high specific
infectivity [24,45,46,47]. If so, then $99% of LA21K or 127S
infectivity would be supported by #10% of PK-resistant PrP
Sc
molecules. Alternatively, infectivity could be mostly associated
with a form of PrP
Sc with low resistance to PK. While a variable,
strain-dependent proportion of abnormal PrP seems fairly PK-
sensitive [28,35,36,48,49], little is known about its specific
infectivity, with two recent studies suggesting that it could be
minimal [37,50]. However, a PK-sensitive and soluble form of
PrP
Sc has been shown to support a substantial fraction of
infectivity [51] and to have a good in vitro converting activity
[35]. The abundance of both PrP
C and other components in the
upper fractions impeded further characterization of the most
infectious PrP
Sc particles in the present study. Classical approaches
based on PrP
Sc conformation-dependent assay [36,49,52] are
unhelpful here; as already shown by others, low sedimenting,
PrP
C-rich fractions contain little or no conformation-dependent
immunoreactive material [28,35]. Also, we failed to detect soluble
or thermolysin-resistant PrP
Sc material that might be indicative of
the presence of PK-sensitive molecules [48,51] in these fractions.
Additional experiments including the titration of PK-treated and
then fractionated infectious material are ongoing to further assess
the protease-resistance of the slow sedimenting component.
What physical properties could account for slow sedimentation
of fast strains infectious component? The detergents employed are
known to produce a high degree of membrane solubilization
[27,28,53,54,55,56], including for GPI-anchored proteins of
detergent-resistant microdomains [26], and they led indeed to
an efficient solubilization of PrP
C (Figure S6E). Dodecyl malto-
side is also known to preserve activity of protein complexes in the
detergent-solubilized state [27]. It is still possible that a tightly
bound cellular component of low density, such as lipid molecule
[45], or low-density lipoprotein [57], remains part of the prion
particles in the most infectious fractions. This would imply that the
tightness of such an interaction specifically differs between strains.
Alternatively, the low sedimenting infectivity component could
involve truly small size PrP
Sc particles. In this hypothesis, the data
would indicate a size smaller than a PrP pentamer, which is
compatible with that reported for PK-sensitive PrP
Sc aggregates
[28,35]. As a means to distinguish between small size and lipid
associated PrP
Sc aggregates, LA21K gradient centrifugation time
was doubled. As a result, infectivity was found to peak in fraction 4
instead of fraction 2 (data not shown). While arguing against lipid
floatation of the most infectious component, this does not exclude
the presence of tightly associated lipids. Additional experiments
will be needed to address this issue.
The neuropathology induced in mice by the fast and slow
sedimenting particles did not differ for a given prion, therefore
Strain Variation in Prion Infectious Particles
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sedimenting infectious particles could reflect a stronger tendency
of large PrP
Sc polymers to fragment. In the case of yeast prions
[PSI
+], it has been proposed that the fittest strains are those whose
large fibers break more easily into smaller oligomers that in turn
act as new seeds for conversion [58], a concept that was then
extended to mammalian prions [59]. In this regard, our
preliminary results indicate that LA21K and 127S PrP
Sc
aggregates exhibit the lowest ‘stability’ among the ovine strains,
as assayed by conformational stability assay.
In addition to providing another measurable criterion of prion
strain-related phenotypic variation, this study revealed the
diversity of their infectious component. Further biochemical and
biophysical investigations will be crucial for a mechanistic
understanding of the replication dynamics of mammalian prions,
in relation with the disease phenotype.
Materials and Methods
Ethics statement
All the experiments involving animals were approved by the
INRA Jouy-en-Josas ethics committee in accordance with the
European Community Council Directive 86/609/EEC.
Prion strains
The ovine prion strains used in this study have been obtained
through serial transmission and subsequent biological cloning by
limiting dilutions of classical and atypical field scrapie and
experimentalsheep BSEsources totg338 transgenicmice expressing
the VRQ allele of ovine PrP. The characterization of their
phenotype in tg338 mice was performed as previously reported
[41,60,61]. Pooled or individual tg338 mouse brain homogenates
(20% wt/vol. in 5% glucose) were used in centrifugation analyses.
Three hamster strains, 139H, Sc237 and ME7H, were also studied.
These strains (kindly provided by R. Carp, Staten Island, NY, USA)
were serially passaged on tg7 transgenic mice expressing hamster
PrP (kindly provided by CSL-Behring (Marburg); [48,62]). Both
139H and Sc237 were subsequently cloned by limiting dilution on
this genetic background. Individual tg7 infected brains (20% wt/
vol.) were used in centrifugation analyses. Non-infected brain tissue
homogenates served as controls.
Sedimentation velocity in iodixanol gradients
The entire procedure was performed at 4uC. Mouse brain
homogenates were solubilized by adding an equal volume of
solubilization buffer (50 mM HEPES pH 7.4, 300 mM NaCl,
10 mM EDTA, 2 mM DTT, 4% (wt/vol.) dodecyl-b-D-maltoside
(Sigma)) and incubated for 30 min on ice. Sarkosyl (N-lauryl
sarcosine; Fluka) was added to a final concentration of 2% (wt/
vol.) and the incubation continued for a further 30 min on ice. A
volume of 150 ml was loaded on a 4.8 ml continuous 10–25%
iodixanol gradient (Optiprep, Axys-shield), unless specified
otherwise, with a final concentration of 25 mM HEPES pH 7.4,
150 mM NaCl, 2 mM EDTA, 1 mM DTT, 0.5% Sarkosyl.
Gradient linearity was verified by refractometry. In standard
experiments (Figure 1), the gradients were centrifuged at
285 000 g for 45 min in a swinging-bucket SW-55 rotor using
an Optima LE-80K ultracentrifuge (Beckman Coulter). Gradients
were then manually segregated into 30 equal fractions of 170 ml
from the bottom using a peristaltic pump. Fractions were aliquoted
for immunoblot or bioassay analyses. The strains were fractionated
in parallel to preserve as much as possible identical experimental
conditions. To avoid any cross-contamination, each piece of the
equipment was thoroughly decontaminated with 5 M NaOH
followed by several rinses in deionised water after each gradient
collection. Standard markers (GE Healthcare, Little Chalfont,
UK) of aldolase (158 kDa), catalase (232 kDa), ferritin (440 kDa)
and thyroglobulin (669 kDa) were run in parallel.
Sedimentation velocity of PK treated brain homogenates
The protocol used was as described above except that PK
(100 mg/ml final concentration; Euromedex, Mundolsheim,
France) was added during the solubilization phase in sarkosyl
(1 h at 37uC).
Sedimentation velocity of semi-purified PrP
Sc (SAF)
Brain homogenates were treated with 20 mg/ml of PK for 1 h at
37uC. The digestion was stopped by the addition of 5 mM
phenylmethylsulfonyl fluoride. The solution was added to 10%
sarkosyl and 10 mM Tris-HCl pH 7.4 and then centrifuged at
175 000 g for 30 min at 20uC on a 10% (wt/vol.) sucrose cushion
in a Beckmann TL100 ultracentrifuge. Pellets were resuspended in
2% (wt/vol.) dodecyl maltoside and the above solubilization/
fractionation protocol was followed.
Sedimentation velocity of recombinant PrP oligomers
Monomeric and oligomeric forms of purified ovine recombinant
PrP [30] were resuspended at a final concentration of 7–10 mMi n
20 mM citrate buffer. An aliquot (150 ml) was loaded onto a 10–
25% iodixanol gradient in citrate buffer and centrifuged at
285 000 g for 45 min in a SW-55 rotor. Gradients were segregated
as described above. Fraction aliquots (20 ml) were analyzed for PrP
content by immunoblot (see below). In these conditions,
recombinant, monomeric PrP was found in the upper fractions
1–3 (not shown).
Analysis of recombinant PrP, PrP
C, PrP
Sc and PK-resistant
PrP
Sc contents by immunoblot
Aliquots of the collected fractions were treated or not with
50 mg/ml PK before methanol precipitation. The pellet was
resuspended in Laemmli buffer and denatured at 100uC for 5 min.
The samples (15 ml) were run on 4–12% NuPAGE gels
(Invitrogen, Cergy Pontoise, France), electrotransferred onto
nitrocellulose membranes, and probed with 0.1 mg/ml biotiny-
lated anti-PrP monoclonal antibody Sha31 as previously described
[60]. Immunoreactivity was visualized by chemiluminescence (GE
Healthcare). The amount of PrP present in each fraction was
determined by the GeneTools software after acquisition of
chemiluminescent signals with a GeneGnome digital imager
(Syngene, Frederick, Maryland, United States).
Analysis of PK-resistant PrP
Sc content by Sandwich ELISA
All Bio-Rad TeSeE detection kit reagents were kindly provided
by S. Simon (CEA, France; [63]). Briefly, aliquots (75 ml) of the
collected fractions were digested with PK (50 mg/ml final
concentration) for 1 h at 37uC before B buffer precipitation and
centrifugation at 28 000 g for 15 min. The pellet was resuspended
in 25 ml of 5 M urea before denaturation at 100uC for 10 min. R6
buffer (200 ml) was subsequently added to the samples and
duplicates were analyzed in microtiter plates coated with anti-
PrP antibody 11C6. The plates were left at room temperature for
2 h. After 3 washes in R2 buffer, 100 ml/well of the enzyme
conjugate (Bar224 anti-PrP antibody) was added for 2 h. The
substrate (100 ml) was added for 30 min and incubated in the dark.
The absorbance was read at 450 nm. A dilution range of ovine,
monomeric recombinant PrP was used for quantification of
relative PK-resistant PrP
Sc levels.
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Sc sedimentation profiles
The PK-resistant PrP
Sc sedimentation profiles obtained by
either immunoblot or ELISA were normalized to units and
decomposed using multiple Gaussians fits procedures with a
maximum entropy minimization approach.
Analysis of thermolysin-resistant PrP
Sc by immunoblot
Fractions were methanol-precipitated. The pellet was resus-
pended in lysis buffer (2% sodium deoxycholate, 2% Triton X-
100, 200 mM Tris-HCl pH 7.4) and mixed with an equal volume
of thermolysin diluted in lysis buffer to yield a final concentration
of 125 mg/ml (unless indicated otherwise) for 1 h at 70uC. The
samples were analyzed by electrophoresis (4–12% gels) and
immunoblotted as above. Blots were probed with either Sha31b
or anti-octarepeat specific Pc248 anti-PrP antibody [64] at a final
concentration of 0.1 mg/ml, before acquisition of chemilumines-
cent signals with a GeneGnome digital imager and analysis by the
GeneTools software (Syngene, Frederick, Maryland, United
States).
Sedimentation assay of PrP species present in the
fractions
Aliquots (20 ml) of the fractions were added to 80 mlo f5 %
glucose before centrifugation at 100 000 g for 1h at 4uCi na
Beckmann TL100 ultracentrifuge to generate soluble (supernatant)
and insoluble (pellet) fractions. Proteins in the supernatant were
precipitated with 400 ml of cold methanol, centrifuged at 16 000 g
for 30 min before denaturation in 100 ml of sample buffer. The
insoluble pellet was resuspended in 20 ml of Laemmli buffer before
denaturation. Samples (20 ml) were analyzed by immunoblot as
described above.
Mouse bioassay for infectivity titration
Fractions 1 to 4 and then every other two fractions (unless
specified otherwise) were diluted extemporarily in 5% glucose
(1:5). This procedure was performed in a class II microbiological
cabinet according to a strict protocol to avoid any cross-
contamination. Individually identified 6- to 10-week old tg338 or
tg7 recipient mice (n=6 mice per fraction) were inoculated
intracerebrally with 20 ml of the solution. Recipient mice
inoculated with fractionated uninfected mouse brain were
euthanized while still healthy at .400 days post-infection. Their
brain was negative for PrP
res content. Mice showing TSE
neurological signs were monitored daily and euthanized in extremis.
Brains were removed and analyzed for PrP
res content by either
immunoblot or histoblot (see below) as a confirmatory test. The
survival time was defined as the number of days from inoculation
to euthanasia.
The survival times of tg338 or tg7 reporter mice was measured
for each tenfold dilution tested during endpoint titration
experiments performed with all but ME7H strains. Animals
inoculated with 2 mg of infectious brain tissue were assigned a
relative infectious dose of 0. From these data, curves representing
the relative infectious dose to survival time were established ([41]
and Figure S5). The different patterns in survival time
distribution among the gradients can thus be looked at as a
function of relative infectious dose so as to estimate what difference
in survival times between inoculated fractions means in terms of
infectivity.
Rov cell assay for infectivity titration
The scrapie cell assay technique will be fully described
elsewhere. Briefly, LA21K gradient fractions aliquots (typically
20–30 mL) were methanol precipitated before resuspension in
culture medium (alpha minimal essential medium supplemented
with 10% fetal bovine serum, 100 U/ml penicillin and 10 mg/ml
streptomycin). We verified that methanol precipitation did not
affect the overall level of infectivity. Rov cell [40] monolayers
established in a 96 well plate were exposed to the fractions for one
week. After several washes, the cells were further cultivated for two
weeks before fixation and PrP
Sc detection by immunofluorescence
as previously described [65]. Immunofluorescence signals were
acquired with an inverted fluorescence microscope (Zeiss Ax-
iovert). A program in NIH Image J software was designed to
quantify the levels of PrP
Sc signal per cell in each well. Serial
tenfold dilutions of LA21K infected brain homogenates were
prepared in the same conditions and run in parallel experiments to
establish a tissue culture infectious doses curve that directly relates
to the percentage of PrP
Sc content.
Histopathology
Brains were rapidly removed from euthanized mice and frozen
on dry ice. Cryosections were cut at 8–10 mm, transferred onto
Superfrost slides and kept at 220uC until use. Histoblot analyses
were performed on 3 brains per infection, using the 12F10 anti-
PrP antibody as described [60]. For thioflavin-S binding, formalin-
or methanol-fixed sections were incubated with 0.01% thioflavin-S
for 1 hour as previously described [66]. Sections were then
incubated with nuclear marker 49, 6-diamidino-2-phenylindole
(Sigma), mounted in fluoromount-G (Interchim) before acquisition
with an inverted fluorescence microscope (Zeiss Axiovert) and
analysis with the Metamorph software.
Accession numbers
The Swiss-Prot accession numbers for the proteins mentioned in
the text are sheep (P23907) and hamster PrP (P04273).
Supporting Information
Figure S1 Effects of the detergents used to solubilize brain
homogenates on the sedimentation properties of PrP
C and PrP
Sc
molecules. Uninfected (A, C) or LA21K infected (B, D) brain
homogenates (20% wt/vol.) were solubilized by adding an equal
volume of standard lysis buffer (1% sodium deoxycholate, 1%
Triton X-100, 100 mM Tris-HCl pH 7.4; A–B) or by 2% sarkosyl
(C–D) for 30 min at 4uC. A volume of 150ml was loaded atop a
iodixanol gradient (5–25% Optiprep in 25mM HEPES, 150mM
NaCl, 1:2 dilution of standard lysis buffer (A–B) or 1% sarkosyl
(C–D)) and centrifuged at 200 000 g for 60 min at 4uC in a SW55
rotor. Fifteen fractions were collected and analyzed for PrP
C (A, C)
and PK-resistant PrP
Sc (B, D) content by immunoblot. Fractions
were numbered from top to bottom of the gradient.
Found at: doi:10.1371/journal.ppat.1000859.s001 (2.01 MB TIF)
Figure S2 PrP
Sc sedimentation velocity profile following solubi-
lization at 37uC, PK digestion or aggregation. (A) LA21K brain
homogenate was solubilized in the same conditions as in the
standard protocol (see Figure 1), except that the temperature was
increased to 37uC. The resulting solution was sedimented by
velocity. (B, C) LA21K brain homogenate was either digested with
100 mg/ml of PK for 1h at 37uC (B) or subjected to a ‘‘scrapie-
associated fibrils’’ protocol (C, see Methods) before applying the
standard fractionation protocol (see Figure 1). All the collected
fractions were analyzed for PK-resistant PrP
Sc content by
immunoblot. For each fraction, the percentage of the total sum
of all PK-resistant PrP
Sc detected on the immunoblot is presented.
Found at: doi:10.1371/journal.ppat.1000859.s002 (0.43 MB TIF)
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Nuclear marker 49, 6-diamidino-2-phenylindole (DAPI, red) and
thioflavin S staining (green) of coronal brain sections from mice
infected with Italian scrapie (SSit; A) or LA21K (B) agent. Note
that in SSit-infected brains, thioflavin S positive plaques were
distributed in a rosary-like array along notably the corpus
callosum. (C) Graph showing the relative amount of SSit PK-
resistant PrP
Sc per fraction after fractionation of infected brain
homogenate in the standardized conditions (see Methods).
Found at: doi:10.1371/journal.ppat.1000859.s003 (3.37 MB TIF)
Figure S4 Regional distribution of PrP
Sc deposits in the brains
of tg338 mice inoculated with sedimentation velocity fractionated
brain homogenates. Tg338 mice were infected intracerebrally with
either crude or fractionated LA21K-infected brain homogenate
(A) or fractionated, sheep BSE-infected brain homogenate (B). The
PrP
Sc deposition pattern in the brains of inoculated mice was
examined by histoblot analysis as previously described [60]. (A)
The intensity of PrP
Sc deposition in several brain regions was
scored. (B) The distribution of PrP
Sc deposits in mice brains is
shown on representative histoblots of 4 different antero-posterior
sections. Note that the staining observed after inoculation of top,
middle and bottom fractions were similar and reminiscent of that
previously reported after inoculation of different BSE-related
agents in tg338 mice [60].
Found at: doi:10.1371/journal.ppat.1000859.s004 (5.23 MB TIF)
Figure S5 Titration of ovine and hamster prion strains
infectivity. (A) Survival time of tg338 mice intracerebrally
inoculated with serial tenfold dilutions of brain homogenate from
LA21K-infected tg338 mice. The mean values measured, the SEM
(error bars) and the number of diseased/inoculated mice for each
dilution are indicated on the right of the plot. Animals inoculated
with the equivalent of 2 mg of infectious brain tissue were assigned
a relative infectious dose of 0. The diseased mice were positive for
brain PrP
res. A regression curve has been drawn from the mean
survival times measured. (B) From this curve, levels of infectivity
expressed (y, in Log (infectious dose)) can be determined from
survival times values (x, in days), using the equation fit to the data.
The constants of the equation are also indicated for all strains for
which an endpoint titration was available.
Found at: doi:10.1371/journal.ppat.1000859.s005 (0.17 MB TIF)
Figure S6 Thermolysin-resistance and insolubility of the PrP
species present in LA21K upper fractions. Uninfected (2)o r
LA21K-infected (+) brain homogenates (A) or pooled fractions 1–2
(B) were treated with thermolysin for 1 h at 70uC at the indicated
concentrations, before immunoblotting with either Sha31 or
Pc248 anti-PrP antibodies, the latter being directed against the
N-terminal part of PrP. (C) The top six fractions from an
uninfected or LA21K-infected gradient were treated with
thermolysin (125 mg/ml final concentration) for 1 h at 70uC
before analysis by immunoblotting with Pc248 antibody. After
measurement of chemoluminescence intensities and normalization
as referred to total protein content, the ratio of LA21K infected to
uninfected signal was calculated for each fraction to determine the
presence of thermolysin-resistant PrP
Sc. The results represent the
mean 6 SEM of 4 independent fractionations, analyzed in
duplicate. (D) Fractions from uninfected and LA21K-infected
gradients were ultracentrifuged at 100 000 g for 1 h at 4uCt o
generate soluble (supernatant) and insoluble (pellet) fractions,
before immunoblot analysis. After measurement of chemolumi-
nescence intensities, the ratio of LA21K infected to uninfected
signal was calculated for the pellet and supernatant of each
fraction (after normalization of total protein content). The results
represent the mean 6 SEM of 4 independent fractionations. (E) A
pool of 1–2 fractions from an uninfected (2) or LA21K-infected
(+) gradient were ultracentrifuged at 100 000 g for 1 h at 4uCt o
generate supernatant (S) and pellet (P) fractions, before immuno-
blot analysis. Note that the vast majority of post-fractionated PrPC
remained associated with the soluble fraction, suggesting efficient
solubilization.
Found at: doi:10.1371/journal.ppat.1000859.s006 (1.46 MB TIF)
Figure S7 Quantification of LA21K infectivity sedimentation
profile by Rov cell assay. The distribution and level of LA21K
infectivity in the gradient was measured using a Rov cell [40] assay
(JC, VB, HL, unpublished data). This assay is based on the
detection of PrP
Sc-containing Rov cells by immunofluorescence
using PrP
Sc-specific antibodies. Rov cells were exposed in parallel
to fraction aliquots and to serial tenfold dilutions (expressed as
relative infectious doses as in Figure 3) of a LA21K-infected brain
homogenate prepared in the same conditions. The culture and
PrP
Sc detection conditions have been optimized to enable a
quantitative relationship between the percentage of PrP
Sc content
(6 SEM) and LA21K infectious titer. The data presented are the
mean of n=2 independent titrations.
Found at: doi:10.1371/journal.ppat.1000859.s007 (0.24 MB TIF)
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